{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/63ea359fe7cacc00111d276a/66c65cbef308cd1af310e8c4?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"37. Holy Grail, CQC, MPox and puberty blockers","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/63ea359fe7cacc00111d276a/1724274600892-62f7f945-0005-44b5-8d0a-d339347da57e.jpeg?height=200","description":"<p>Steve and Helen fresh from their Summer holidays discuss the top new stories of the past couple of weeks, including the CQC, criticisms of GRAIL multi-cancer early detection tests, Mpox and puberty blockers among other things. Want to ask a question for next episode? Drop a quick email to podcast@stevebrine.com or find us on social media at 'Prevention is the new cure'.</p>","author_name":"Steve Brine & James Bethell"}